Bloodstream Infections and Infective Endocarditis — Viva Defence

Opening statement (SASPOP, delivered aloud)

"Mr Kelly is a 58-year-old man with early prosthetic-valve endocarditis — staphylococcal, with a paravalvular abscess — complicated by a septic embolic stroke without haemorrhagic transformation. His main problems are: active endovascular infection with uncontrolled local extension; neurological injury from embolism; the anticoagulation dilemma of a mechanical valve in the setting of a fresh septic infarct; and the near-certain need for redo valve surgery. My priorities are organism-directed intravenous therapy for a counted six weeks, urgent surgical review, brain imaging to guide anticoagulation, and a multidisciplinary decision about timing." [1] [2]

Structured problem list

1. Early prosthetic-valve endocarditis — CoNS in all three sets is a true pathogen here, not contamination; the paravalvular abscess places him in the "uncontrolled infection" surgical indication group [3] [2].
2. Septic embolic stroke — right MCA infarct, no haemorrhage on initial CT; embolic risk in endocarditis tracks with S. aureus aetiology, vegetation size and mobility, prior embolism and atrial fibrillation [6].
3. Mechanical valve thromboprophylaxis — warfarin cannot simply stop indefinitely; each decision trades haemorrhagic transformation against valve thrombosis [1].
4. Surgical candidacy and timing — redo sternotomy, active infection, fresh cerebral infarct: the multidisciplinary team owns this, not the registrar [2].
5. Six weeks of intravenous therapy logistics — venous access, monitoring, and what happens if cultures persist [1].

Integrated management plan

• Antimicrobials: organism-directed intravenous therapy for prosthetic-valve staphylococcal endocarditis — a beta-lactam backbone if susceptible (vancomycin if MRSE), with guideline-specified rifampicin and an initial aminoglycoside — for a minimum of six weeks counted from the first negative blood culture, with repeat cultures every 24–48 hours until clearance is documented [1] [2].
• Surgery: refer urgently to the endocarditis team. The abscess is uncontrolled infection; his stroke is ischaemic without haemorrhage, which is not a reason to delay indicated valve surgery. Intracranial haemorrhage would be — that usually mandates a delay of at least two weeks [2] [4].
• Anticoagulation: pause warfarin briefly after this significant septic cerebral embolus, repeat brain imaging, and restart once haemorrhage is excluded — a mechanical mitral valve cannot sit unanticoagulated for long. The decision is documented as a joint cardiology, neurology and ID decision [1].
• Monitor and screen: daily neurological observations, repeat CT if any deterioration (haemorrhagic transformation or mycotic aneurysm), ECG surveillance for new conduction block from the abscess, and screening for further emboli (spleen, kidneys, limbs) [1] [6].

Probing questions with model answers

"Why six weeks, and from when do you count?" — "Prosthetic-valve endocarditis is treated for a minimum of six weeks of intravenous therapy, counted from the first negative blood culture — not from admission, and not from the first dose. Persistent positive cultures would reset the clock and tell me the source is uncontrolled, which itself is a surgical indication" [1].

"He is stable and responding on day 14. Can he finish the course orally like the POET patients?" — "No. POET enrolled stable left-sided endocarditis on native valves; prosthetic-valve disease, an abscess, and an actively complicated course are precisely the patients the oral step-down does not cover. He completes intravenous therapy" [5].

"The surgeons are nervous about operating four days after a stroke. What is your position?" — "An ischaemic stroke without haemorrhage is not, by itself, a reason to delay indicated valve surgery — his abscess defines the indication and waiting seeds more emboli. If repeat imaging showed haemorrhagic transformation, I would join the surgeons in delaying, generally at least two weeks, because cardiopulmonary bypass anticoagulation in a haemorrhagic brain is dangerous" [2] [4].

"His INR is 1.2 and the team asks you what to do about warfarin tonight." — "I would hold warfarin now, after a significant septic cerebral embolus, and arrange repeat brain imaging. Once haemorrhage is excluded I would restart anticoagulation — his mechanical mitral valve carries real thrombosis risk, and indefinite cessation is not a safe default. If he needed early surgery, the surgical team would manage anticoagulation around bypass" [1].

"If the CT had shown a mycotic aneurysm?" — "That changes the conversation: I would involve neurosurgery and interventional neuroradiology early — unruptured aneurysms can sometimes be followed or treated endovascularly, but a ruptured intracranial mycotic aneurysm takes priority over the valve and forces a delay to cardiac surgery" [1].

Communication points

• Explain to Mr Kelly and his family what prosthetic-valve endocarditis means: weeks of intravenous therapy, likely redo surgery, and the stroke's implications — in plain language, with time for questions [1].
• Be explicit that decisions here are multidisciplinary: cardiology, cardiothoracic surgery, infectious diseases, neurology — and that the patient's values shape the risk conversation around redo surgery [2].
• Document the anticoagulation reasoning carefully — the balance struck, the imaging relied upon, and who was involved [1].